Narcolepsy Therapeutics Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Narcolepsy Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 Central nervous system stimulants
1.2.3 Sodium Oxybate
1.2.4 Selective Serotonin Reuptake Inhibitor (SSRI)
1.2.5 Tricyclic Antidepressants
1.2.6 Others
1.3 Market by Application
1.3.1 Global Narcolepsy Therapeutics Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Narcolepsy With Cataplexy
1.3.3 Narcolepsy Without Cataplexy
1.3.4 Secondary Narcolepsy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Narcolepsy Therapeutics Market Perspective (2018-2032)
2.2 Narcolepsy Therapeutics Growth Trends by Region
2.2.1 Narcolepsy Therapeutics Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 Narcolepsy Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Narcolepsy Therapeutics Forecasted Market Size by Region (2023-2032)
2.3 Narcolepsy Therapeutics Market Dynamics
2.3.1 Narcolepsy Therapeutics Industry Trends
2.3.2 Narcolepsy Therapeutics Market Drivers
2.3.3 Narcolepsy Therapeutics Market Challenges
2.3.4 Narcolepsy Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Narcolepsy Therapeutics Players by Revenue
3.1.1 Global Top Narcolepsy Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Narcolepsy Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Narcolepsy Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Narcolepsy Therapeutics Revenue
3.4 Global Narcolepsy Therapeutics Market Concentration Ratio
3.4.1 Global Narcolepsy Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Narcolepsy Therapeutics Revenue in 2022
3.5 Narcolepsy Therapeutics Key Players Head office and Area Served
3.6 Key Players Narcolepsy Therapeutics Product Solution and Service
3.7 Date of Enter into Narcolepsy Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Narcolepsy Therapeutics Breakdown Data by Type
4.1 Global Narcolepsy Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Narcolepsy Therapeutics Forecasted Market Size by Type (2023-2032)
5 Narcolepsy Therapeutics Breakdown Data by Application
5.1 Global Narcolepsy Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Narcolepsy Therapeutics Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Narcolepsy Therapeutics Market Size (2018-2032)
6.2 North America Narcolepsy Therapeutics Market Size by Country (2018-2023)
6.3 North America Narcolepsy Therapeutics Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Narcolepsy Therapeutics Market Size (2018-2032)
7.2 Europe Narcolepsy Therapeutics Market Size by Country (2018-2023)
7.3 Europe Narcolepsy Therapeutics Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Narcolepsy Therapeutics Market Size (2018-2032)
8.2 Asia-Pacific Narcolepsy Therapeutics Market Size by Country (2018-2023)
8.3 Asia-Pacific Narcolepsy Therapeutics Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Narcolepsy Therapeutics Market Size (2018-2032)
9.2 Latin America Narcolepsy Therapeutics Market Size by Country (2018-2023)
9.3 Latin America Narcolepsy Therapeutics Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Narcolepsy Therapeutics Market Size (2018-2032)
10.2 Middle East & Africa Narcolepsy Therapeutics Market Size by Country (2018-2023)
10.3 Middle East & Africa Narcolepsy Therapeutics Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Addrenex Pharmaceuticals, Inc.
11.1.1 Addrenex Pharmaceuticals, Inc. Company Detail
11.1.2 Addrenex Pharmaceuticals, Inc. Business Overview
11.1.3 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
11.1.4 Addrenex Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2018-2023)
11.1.5 Addrenex Pharmaceuticals, Inc. Recent Development
11.2 Teva Pharmaceutical Industries Ltd.
11.2.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.2.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.2.3 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Introduction
11.2.4 Teva Pharmaceutical Industries Ltd. Revenue in Narcolepsy Therapeutics Business (2018-2023)
11.2.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.3 Jazz Pharmaceuticals PLC
11.3.1 Jazz Pharmaceuticals PLC Company Detail
11.3.2 Jazz Pharmaceuticals PLC Business Overview
11.3.3 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Introduction
11.3.4 Jazz Pharmaceuticals PLC Revenue in Narcolepsy Therapeutics Business (2018-2023)
11.3.5 Jazz Pharmaceuticals PLC Recent Development
11.4 Graymark Healthcare, Inc.
11.4.1 Graymark Healthcare, Inc. Company Detail
11.4.2 Graymark Healthcare, Inc. Business Overview
11.4.3 Graymark Healthcare, Inc. Narcolepsy Therapeutics Introduction
11.4.4 Graymark Healthcare, Inc. Revenue in Narcolepsy Therapeutics Business (2018-2023)
11.4.5 Graymark Healthcare, Inc. Recent Development
11.5 Arena Pharmaceuticals, Inc.
11.5.1 Arena Pharmaceuticals, Inc. Company Detail
11.5.2 Arena Pharmaceuticals, Inc. Business Overview
11.5.3 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
11.5.4 Arena Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2018-2023)
11.5.5 Arena Pharmaceuticals, Inc. Recent Development
11.6 BIOPROJET
11.6.1 BIOPROJET Company Detail
11.6.2 BIOPROJET Business Overview
11.6.3 BIOPROJET Narcolepsy Therapeutics Introduction
11.6.4 BIOPROJET Revenue in Narcolepsy Therapeutics Business (2018-2023)
11.6.5 BIOPROJET Recent Development
11.7 Takeda
11.7.1 Takeda Company Detail
11.7.2 Takeda Business Overview
11.7.3 Takeda Narcolepsy Therapeutics Introduction
11.7.4 Takeda Revenue in Narcolepsy Therapeutics Business (2018-2023)
11.7.5 Takeda Recent Development
11.8 Ligand Pharmaceuticals, Inc.
11.8.1 Ligand Pharmaceuticals, Inc. Company Detail
11.8.2 Ligand Pharmaceuticals, Inc. Business Overview
11.8.3 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Introduction
11.8.4 Ligand Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2018-2023)
11.8.5 Ligand Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Narcolepsy Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2032
Table 2. Key Players of Central nervous system stimulants
Table 3. Key Players of Sodium Oxybate
Table 4. Key Players of Selective Serotonin Reuptake Inhibitor (SSRI)
Table 5. Key Players of Tricyclic Antidepressants
Table 6. Key Players of Others
Table 7. Global Narcolepsy Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2032
Table 8. Global Narcolepsy Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2032
Table 9. Global Narcolepsy Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Narcolepsy Therapeutics Market Share by Region (2018-2023)
Table 11. Global Narcolepsy Therapeutics Forecasted Market Size by Region (2023-2032) & (US$ Million)
Table 12. Global Narcolepsy Therapeutics Market Share by Region (2023-2032)
Table 13. Narcolepsy Therapeutics Market Trends
Table 14. Narcolepsy Therapeutics Market Drivers
Table 15. Narcolepsy Therapeutics Market Challenges
Table 16. Narcolepsy Therapeutics Market Restraints
Table 17. Global Narcolepsy Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Narcolepsy Therapeutics Market Share by Players (2018-2023)
Table 19. Global Top Narcolepsy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcolepsy Therapeutics as of 2022)
Table 20. Ranking of Global Top Narcolepsy Therapeutics Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Narcolepsy Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Narcolepsy Therapeutics Product Solution and Service
Table 24. Date of Enter into Narcolepsy Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Narcolepsy Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Narcolepsy Therapeutics Revenue Market Share by Type (2018-2023)
Table 28. Global Narcolepsy Therapeutics Forecasted Market Size by Type (2023-2032) & (US$ Million)
Table 29. Global Narcolepsy Therapeutics Revenue Market Share by Type (2023-2032)
Table 30. Global Narcolepsy Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Narcolepsy Therapeutics Revenue Market Share by Application (2018-2023)
Table 32. Global Narcolepsy Therapeutics Forecasted Market Size by Application (2023-2032) & (US$ Million)
Table 33. Global Narcolepsy Therapeutics Revenue Market Share by Application (2023-2032)
Table 34. North America Narcolepsy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Narcolepsy Therapeutics Market Size by Country (2023-2032) & (US$ Million)
Table 36. Europe Narcolepsy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Narcolepsy Therapeutics Market Size by Country (2023-2032) & (US$ Million)
Table 38. Asia-Pacific Narcolepsy Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Narcolepsy Therapeutics Market Size by Region (2023-2032) & (US$ Million)
Table 40. Latin America Narcolepsy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Narcolepsy Therapeutics Market Size by Country (2023-2032) & (US$ Million)
Table 42. Middle East & Africa Narcolepsy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Middle East & Africa Narcolepsy Therapeutics Market Size by Country (2023-2032) & (US$ Million)
Table 44. Addrenex Pharmaceuticals, Inc. Company Detail
Table 45. Addrenex Pharmaceuticals, Inc. Business Overview
Table 46. Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Product
Table 47. Addrenex Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2018-2023) & (US$ Million)
Table 48. Addrenex Pharmaceuticals, Inc. Recent Development
Table 49. Teva Pharmaceutical Industries Ltd. Company Detail
Table 50. Teva Pharmaceutical Industries Ltd. Business Overview
Table 51. Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Product
Table 52. Teva Pharmaceutical Industries Ltd. Revenue in Narcolepsy Therapeutics Business (2018-2023) & (US$ Million)
Table 53. Teva Pharmaceutical Industries Ltd. Recent Development
Table 54. Jazz Pharmaceuticals PLC Company Detail
Table 55. Jazz Pharmaceuticals PLC Business Overview
Table 56. Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Product
Table 57. Jazz Pharmaceuticals PLC Revenue in Narcolepsy Therapeutics Business (2018-2023) & (US$ Million)
Table 58. Jazz Pharmaceuticals PLC Recent Development
Table 59. Graymark Healthcare, Inc. Company Detail
Table 60. Graymark Healthcare, Inc. Business Overview
Table 61. Graymark Healthcare, Inc. Narcolepsy Therapeutics Product
Table 62. Graymark Healthcare, Inc. Revenue in Narcolepsy Therapeutics Business (2018-2023) & (US$ Million)
Table 63. Graymark Healthcare, Inc. Recent Development
Table 64. Arena Pharmaceuticals, Inc. Company Detail
Table 65. Arena Pharmaceuticals, Inc. Business Overview
Table 66. Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Product
Table 67. Arena Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2018-2023) & (US$ Million)
Table 68. Arena Pharmaceuticals, Inc. Recent Development
Table 69. BIOPROJET Company Detail
Table 70. BIOPROJET Business Overview
Table 71. BIOPROJET Narcolepsy Therapeutics Product
Table 72. BIOPROJET Revenue in Narcolepsy Therapeutics Business (2018-2023) & (US$ Million)
Table 73. BIOPROJET Recent Development
Table 74. Takeda Company Detail
Table 75. Takeda Business Overview
Table 76. Takeda Narcolepsy Therapeutics Product
Table 77. Takeda Revenue in Narcolepsy Therapeutics Business (2018-2023) & (US$ Million)
Table 78. Takeda Recent Development
Table 79. Ligand Pharmaceuticals, Inc. Company Detail
Table 80. Ligand Pharmaceuticals, Inc. Business Overview
Table 81. Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Product
Table 82. Ligand Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2018-2023) & (US$ Million)
Table 83. Ligand Pharmaceuticals, Inc. Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Narcolepsy Therapeutics Market Share by Type: 2022 VS 2032
Figure 2. Central nervous system stimulants Features
Figure 3. Sodium Oxybate Features
Figure 4. Selective Serotonin Reuptake Inhibitor (SSRI) Features
Figure 5. Tricyclic Antidepressants Features
Figure 6. Others Features
Figure 7. Global Narcolepsy Therapeutics Market Share by Application in 2022 & 2032
Figure 8. Narcolepsy With Cataplexy Case Studies
Figure 9. Narcolepsy Without Cataplexy Case Studies
Figure 10. Secondary Narcolepsy Case Studies
Figure 11. Narcolepsy Therapeutics Report Years Considered
Figure 12. Global Narcolepsy Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2032
Figure 13. Global Narcolepsy Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2032
Figure 14. Global Narcolepsy Therapeutics Market Share by Region: 2022 VS 2032
Figure 15. Global Narcolepsy Therapeutics Market Share by Players in 2022
Figure 16. Global Top Narcolepsy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcolepsy Therapeutics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Narcolepsy Therapeutics Revenue in 2022
Figure 18. North America Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 19. North America Narcolepsy Therapeutics Market Share by Country (2018-2032)
Figure 20. United States Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 21. Canada Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 22. Europe Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 23. Europe Narcolepsy Therapeutics Market Share by Country (2018-2032)
Figure 24. Germany Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 25. France Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 26. U.K. Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 27. Italy Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 28. Russia Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 29. Nordic Countries Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 30. Asia-Pacific Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 31. Asia-Pacific Narcolepsy Therapeutics Market Share by Region (2018-2032)
Figure 32. China Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 33. Japan Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 34. South Korea Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 35. Southeast Asia Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 36. India Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 37. Australia Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 38. Latin America Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 39. Latin America Narcolepsy Therapeutics Market Share by Country (2018-2032)
Figure 40. Mexico Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 41. Brazil Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 42. Middle East & Africa Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 43. Middle East & Africa Narcolepsy Therapeutics Market Share by Country (2018-2032)
Figure 44. Turkey Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 45. Saudi Arabia Narcolepsy Therapeutics Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 46. Addrenex Pharmaceuticals, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2018-2023)
Figure 47. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Narcolepsy Therapeutics Business (2018-2023)
Figure 48. Jazz Pharmaceuticals PLC Revenue Growth Rate in Narcolepsy Therapeutics Business (2018-2023)
Figure 49. Graymark Healthcare, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2018-2023)
Figure 50. Arena Pharmaceuticals, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2018-2023)
Figure 51. BIOPROJET Revenue Growth Rate in Narcolepsy Therapeutics Business (2018-2023)
Figure 52. Takeda Revenue Growth Rate in Narcolepsy Therapeutics Business (2018-2023)
Figure 53. Ligand Pharmaceuticals, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Industry Market Size
